CD8A and B-cell chronic lymphocytic leukemia: Functional studies showed that BTLA blockade increased the percentage of IFNγ + NK-cells and IFNγ + CD8 + T-cells, decreased the secretion of IL-10 by CLL B-cells, and increased tumor cell lysis.